SEC Form 4 · accession 0001179110-19-003767
OMNICELL, INC. · OMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter J. Kuipers
Officer — Executive V P& CFO
Period of report
Mar 11, 2019
Accepted (ET)
Mar 12, 2019 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000926326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Mar 11, 2019 | S | 2,224 | $83.00 | D | 56,873 | D | |
| Common Stock | Mar 12, 2019 | M | 22,280 | $0.00 | A | 79,153 | D | |
| Common StockF3 | Mar 12, 2019 | S | 8,901 | $84.0699 | D | 70,252 | D | |
| Common StockF4 | Mar 12, 2019 | S | 13,379 | $84.0699 | D | 56,873 | D | |
| Common Stock | holding | — | — | — | 59,097 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options NQ (Right to buy) | $27.70 | Mar 12, 2019 | M | 1,094 | D | Feb 4, 2017 | Feb 3, 2026 | Common Stock | 1,094 | 0 | D |
| Stock Options NQ (Right to buy) | $32.78 | Mar 12, 2019 | M | 2,345 | D | Sep 1, 2016 | Aug 31, 2025 | Common Stock | 2,345 | 0 | D |
| Stock Options NQ (Right to buy) | $36.70 | Mar 12, 2019 | M | 13,621 | D | Feb 8, 2018 | Feb 7, 2027 | Common Stock | 13,621 | 0 | D |
| Stock Options NQ (Right to buy) | $44.25 | Mar 12, 2019 | M | 5,220 | D | Feb 6, 2019 | Feb 5, 2028 | Common Stock | 5,220 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is the exact price of $83.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan.
- F3The price reported in Column 4 is the average price of $84.0699. The sold price range between $83.02 to $83.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4The price reported in Column 4 is the average price of $84.0699. The sold price range between $84.00 to $84.71. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.